Morgan Stanley Insti Fd Advantage Portfolio Cl I (MPAIX) Fund Overview
Morgan Stanley Insti Fd Advantage Portfolio Cl I (MPAIX) — price $26.75 (-1.98%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Morgan Stanley Insti Fd Advantage Portfolio Cl I · MPAIX
The fund seeks companies with strong brand recognition and sustainable competitive advantages, with the flexibility to invest in foreign and privately placed securities.
Price as of Nov 19, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $26.75 |
| Change on the day | -1.98% |
| Price / earnings (trailing) | 3.56 |
Price & events
What is Morgan Stanley Insti Fd Advantage Portfolio Cl I (MPAIX), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Morgan Stanley Insti Fd Advantage Portfolio Cl I (MPAIX) is the company analyzed here. In Q2 FY2025 it reported revenue of $16.60B and net income of $3.54B.
What do the latest results show for Morgan Stanley Insti Fd Advantage Portfolio Cl I (MPAIX)?
Short answer · as of
The most recent reported quarter, Q2 FY2025, carried revenue of $16.60B.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2025 | $16.60B | $3.54B | $2.13 (diluted) |
| Q1 FY2025 | $17.60B | $4.32B | $2.60 (diluted) |
| Q4 FY2024 | $16.11B | $3.71B | $2.22 (diluted) |
| Q3 FY2024 | $15.30B | $3.19B | $1.88 (diluted) |
What are the financial strengths and risks for Morgan Stanley Insti Fd Advantage Portfolio Cl I (MPAIX)?
Short answer · as of
The distress and quality screens read Altman Z 0.26 · Piotroski F 3. Trailing ratios: ROE 13.2% · ROA 1.1% · current ratio 26.76.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 0.26 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MPAIX in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported MPAIX in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What Investors Ask About Morgan Stanley Insti Fd Advantage Portfolio Cl I (MPAIX)
These answers are editorial: 1 of these 1 answer is drawn from the MPAIX research dossier (written Mar 17, 2026 by gemini-2.0-flash). Figures in this section are not part of the source register.
How sensitive is MPAIX to interest rate changes?
As a fund primarily investing in equities, MPAIX's direct sensitivity to interest rate changes is less pronounced compared to fixed-income investments. However, interest rate changes can indirectly impact the fund.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 9 figures on this page — 7 from Financial Modeling Prep (FMP) and 2 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com